We invite you to submit an abstract for presentation at the 25th American Peptide Symposium.
We are no longer accepting oral presentations for APS 2017. However, we are accepting submissions for late-breaking poster presentations.
Abstract Submission Dates: October 18th, 2016 to May 22nd, 2017, at midnight Notifications Emailed to Lead Author: March 20th, 2017, if abstract is submitted by February 15th.
Late Breaking Poster Abstracts are not guaranteed placement in the program book if submitted after April 15, but will be included in the delegate registration packet as an addendum to the program.
Appropriate topics for poster presentation include:
Peptide Materials and Nanomedicine
Peptides and Enzymes
Natural Product Biosynthesis
Peptide Arrays and Proteomics
Synthetic and Non-Natural Peptide Backbones
Peptide Therapeutics, Vaccines, and Diagnostics
Peptide Structure and Function
Length: The body of the abstract - 250 words, about half a page of text. Format: Word. PDF only if abstract includes a diagram. Font: Times New Roman
Uploading to text box on submission form:
When uploading your abstract to the text box on the submission form,
include title, author/s and affiliation/s as well as the complete
abstract. Do NOT upload only the body of the abstract.
Type of submission:
When completing the submission form, you will be given the option of selecting:
POSTER PRESENTATION ONLY
All abstracts for poster only presentation must be submitted by the January 31st deadline.
ORAL PRESENTATION ONLY
All abstracts submitted for oral presentation must be submitted by the January 31st deadline.
FIRST PREFERENCE ORAL PRESENTATION.
If not accepted, please consider for
All abstracts submitted for first preference oral presentation must be submitted by the January 31st deadline.
Young Investigator Poster Competition:
In addition to choosing one of the submission options, poster only, oral only, or first preference oral, Young Investigators may elect to enter the Young Investigator’s Poster Competition.
Young Investigators are defined as undergraduates, graduates and post docs.
Young Investigators who are chosen to present orally will automatically be entered into the ESCOM Science Foundation Oral Presentation Competition. Three winners will receive cash prizes.
Special Thanks to the ESCOM Science Foundation
ESCOM Science Foundation, founded by Dr. Bert L. Schram and currently chaired by Mrs. Dr. E.A. Schram, has kindly sponsored three awards to be given to the top three outstanding oral presentations given by young investigators. In addition, the Foundation also sponsors the Dr. Bert L. Schram Young Scientists’ Lunch and Mixer. The American Peptide Society acknowledges this generous contribution, which supports the development and promotion of young aspiring researchers in peptide science.
We will begin accepting abstracts on October 18, 2016
Ipsen US, comprised of Ipsen Biopharmaceuticals, Inc., and Ipsen Bioscience, Inc., is driven by a passion to improve the lives of patients. A search for innovative solutions to disabling conditions is at the heart of everything we do. We are inspired to find effective therapeutic options to treat diseases, relieve suffering, and bring value to the community.
Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry.
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification.
Ferring Pharmaceuticals Inc. is a research-driven biopharmaceutical company devoted to commercialization of innovative products in the fields of infertility and reproductive health, gastroenterology, gynecology, orthopaedics and urology.
Expertise and deep knowledge in providing peptide synthesis and bioanalytical tools
At PolyPeptide, going the extra mile with our customers is a priority. Agility, global presence, flexibility, ability to create fast-tailored solutions, and exceeding the highest requirements, are all key benefits that you could only expect from a world leader in peptide manufacturing.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
Zealand Pharma is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi, Boehringer Ingelheim and Helsinn and a pipeline of proprietary product candidates, which primarily target specialty diseases with significant unmet needs.
CPC Scientific is a global provider of high-quality cGMP and custom peptides to researchers and pharmaceutical companies.
DAISO offers you highly reproducible and predictable DAISOGEL® analytical and preparative columns for proteins, peptides, and organic compounds.
We manufacture and distribute consumables and instruments for research and industry.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Amgen is one of the world’s leading biotechnology companies.
Chemical and Biopharmaceutical Laboratories is a global peptide manufacturing technology company founded in 1990 to provide the industry with novel chemistries in key areas of solid phase peptide and organic synthesis.
CEM Corporation, a private company based in Matthews, North Carolina, is the leading provider of microwave laboratory instrumentation.
ChemPep®, a bioscience company located in Wellington, Florida, provides innovative products and services for R&D in the areas of organic chemistry, biochemistry, molecular biology, solid phase synthesis, peptide and combinatorial chemistry.
Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ - medicines that have the potential to transform the prevention and management of serious chronic diseases.
We are a global healthcare company with a 125-year history of working to make a difference.
Peptides International manufactures and distributes a wide variety of products that are used in major research institutions throughout the world.
The aim of Peptide Science is to publish significant original research papers and comprehensive reviews covering the whole spectrum of peptide science including synthesis, structure and bioactivity.
With 25,000 researchers testing 8000 new compounds every year, our science is our foundation. It is created by our people, drives our purpose, and creates our products.
Ra Pharma® utilizes a process called “mRNA display” and the Extreme Diversity™ platform to produce extremely large and diverse libraries of peptides from which to screen for potential product candidates.
Scilligence facilitates Science with Intelligence
Bioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials.
ACS Combinatorial Science publishes research describing the development and use of combinatorial, high-throughput, and related methods in chemistry, materials science, and biology.